港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

生物醫藥B類股

618.706

+13.1722.18%

漲家數：23

跌家數：8

平家數：3

市盈率：- -

高：627.633

開：605.584

低：600.085

收：605.533

成交量：1.29億

成交額：38.26億

市值：3,831.01億

流通市值：3,410.50億

資料載入中...

10月31日港股藥品及生物科技行業沽空數據盤點，石藥集團、康方生物、中國生物製藥沽空金額位居行業前三

证券之星APP

京東健康與醫療器械企業「雙向賦能」共建數字化健康新生態——走進魚躍全球產業化基地

速遞｜歌禮制藥Amylin減肥新藥向FDA申報！進入臨牀開發階段

GLP1减重宝典

聖湘生物(688289.SH)四款產品取得醫療器械註冊證

藥明巨諾與再生元簽署戰略合作補充協議，攜手加速TCR-T療法開發

2025年西藥行業市場發展現狀趨勢分析

2025 ESMO口頭報告︱恆瑞創新藥HRS-7058治療KRAS G12C突變實體瘤I期研究結果發佈

和譽醫藥2025研發日成功舉辦，展示創新管線佈局與前沿臨牀進展

医药魔方Info

諾誠健華11月13日舉行董事會會議考慮及批准第三季度業績

每日沽空追蹤 | 諾誠健華 10月31日沽空量成交151.5萬股，沽空比例為10.07%

每日沽空追蹤 | 亞盛醫藥-B 10月31日沽空量成交32.41萬股，沽空比例為9.71%

每日沽空追蹤 | 華領醫藥-B 10月31日沽空量成交13.3萬股，沽空比例為3.66%

每日沽空追蹤 | 科濟藥業-B 10月31日沽空量成交13.9萬股，沽空比例為21.19%

每日沽空追蹤 | 歌禮制藥-B 10月31日沽空量成交30.4萬股，沽空比例為8.11%

21個獨家中成藥火熱！華潤、國藥領跑，雲南白藥暴漲396%，28款中藥新藥瞄準百億市場

復宏漢霖CEO朱儁：創新藥出海忌迷信經驗、「倚老賣老」｜36氪專訪

心瑋醫療-B10月31日主力淨流入21.2萬元散户資金拋售

歌禮制藥-B10月31日獲主力加倉577.7萬元

沛嘉醫療-B10月31日主力淨流入59.5萬元散户資金拋售

邁博藥業-B10月31日主力淨流出25.4萬元散户資金買入

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":618.7055,"timestamp":1761898110601,"preClose":605.53326,"halted":0,"volume":128593457,"delay":0,"changeRate":0.021753,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":13.172241,"latestTime":"10-31 16:00:00","open":605.58374,"high":627.6333,"low":600.08484,"amount":3826218301,"amplitude":0.045495,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1761874200000,1761883200000],[1761886800000,1761897600000]],"pbRate":5.343409,"peRate":-44.036334,"turnoverRate":0.004666,"increases":23,"decrements":9,"flats":1,"marketCap":383100705664,"floatMarketCap":341050329040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":627.6333,"amplitude":0.045495,"preClose":605.53326,"low":600.08484,"pbRate":"5.343409","latestPrice":618.7055,"volume":128593457,"delay":0,"open":605.58374,"prevYearClose":331.1933,"prevWeekClose":617.318,"prevMonthClose":618.706,"prevQuarterClose":752.859,"fiveDayClose":615.593,"twentyDayClose":752.859,"sixtyDayClose":779.344,"secType":"PLATE","market":"HK","turnoverRate":0.004666,"peRate":-44.036334,"marketCap":383100705664,"floatMarketCap":341050329040,"timestamp":1761898110601,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":23,"down":8,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2580842321","title":"10月31日港股藥品及生物科技行業沽空數據盤點，石藥集團、康方生物、中國生物製藥沽空金額位居行業前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2580842321","media":"证券之星APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580842321?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 18:06","pubTimestamp":1761905164,"startTime":"0","endTime":"0","summary":"证券之星消息，10月31日港交所披露数据显示，当日港股药品及生物科技行业的158只个股中有70只被沽空，总沽空股数为1.76亿股，总沽空金额为29.03亿元（港元），而当日药品及生物科技行业的总成交金额为221.2亿元（港元），沽空比例为13.12%。从沽空金额来看，石药集团、康方生物、中国生物制药沽空金额位居行业前三，分别为4.46亿港元、3.36亿港元、2.51亿港元。沽空与卖空含义相同，即在并不持有股票的前提下，通过借入股票获得筹码进而卖出。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031181252974c1d4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031181252974c1d4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","LU0348825331.USD","LU1720050803.USD","IE00BZ08YS42.EUR","LU1807302812.USD","09926","LU1226288170.HKD","01093","LU1008478684.HKD","SG9999004220.SGD","LU0540923850.HKD","BK1589","IE00BZ08YT58.USD","01177","LU1993786604.SGD","BK1521","LU0417516738.SGD","LU1226288253.USD","LU0067412154.USD","LU2476274720.SGD","LU1152091168.USD","LU2039709279.SGD","LU2778985437.USD","IE00BPRC5H50.USD","LU0561508036.HKD","LU0417516902.SGD","IE0008368742.USD","LU0348784397.USD","LU1960683339.HKD","LU1328277881.USD","LU0140636845.USD","LU0348767384.USD","LU2399975544.HKD","LU0417516571.SGD","BK1574","LU0501845795.SGD","LU1226287529.USD","BK1161","LU0348827113.USD","LU2488822045.USD","IE00B031HY20.USD","LU0348766576.USD","LU0880133367.SGD","LU1794554557.SGD","LU2476274308.USD","LU0315179316.USD","LU0348783233.USD","LU1152091754.HKD","LU1951186391.HKD","LU1226287792.SGD"],"gpt_icon":0},{"id":"2579452089","title":"京東健康與醫療器械企業「雙向賦能」共建數字化健康新生態——走進魚躍全球產業化基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2579452089","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579452089?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:55","pubTimestamp":1761904500,"startTime":"0","endTime":"0","summary":"京东健康与鱼跃医疗在江苏丹阳的全球产业化基地展开深度合作，共建数字化健康新生态。京东健康通过其供应链网络，助力鱼跃医疗的智能医疗器械高效触达全国患者与家庭，实现从制造到终端的全链路服务。双方合作不仅是销售渠道的对接，更是基于数字化与供应链能力的深度共建。京东健康依托全国仓储物流体系，提升鱼跃产品流通效率，实现“当日达”“次日达”。同时，京东健康供应链管理系统与鱼跃制造体系高效协同，通过消费大数据动态调整布货计划，精准响应市场需求。此外，京东健康还助力鱼跃从“制造”转向“智造”，基于用户数据洞察推出具有房颤识别功能的电子血压计等创新产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180724a47fc569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180724a47fc569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","LU0051755006.USD","SGXZ86797644.SGD","BK1589","09997","BK1100","BK1615","BK1574","BK1142","BK1591","BK1515","09996","BK1571","BK1247","LU0456827905.SGD","86618","06618","SGXZ62798434.SGD","BK1583"],"gpt_icon":0},{"id":"2580416212","title":"速遞｜歌禮制藥Amylin減肥新藥向FDA申報！進入臨牀開發階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416212","media":"GLP1减重宝典","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416212?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:53","pubTimestamp":1761904426,"startTime":"0","endTime":"0","summary":"整理 | GLP1减重宝典内容团队2025年10月30日，歌礼制药有限公司宣布，已选定一款有望成为同类最佳每月一次皮下注射胰淀素受体激动剂ASC36作为临床开发候选药物。歌礼预计将于2026年第二季度向美国食品药品监督管理局递交ASC36治疗肥胖症的新药临床试验申请。ASC36是利用歌礼基于结构的AI辅助药物发现和超长效药物开发平台技术自主研发的胰淀素受体激动剂多肽。每毫克多肽的减重效果更优，也可能使ASC36在规模化生产中成本更低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031200933a47ffba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031200933a47ffba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01477","01672","BK1574","BK1515","BK1191"],"gpt_icon":0},{"id":"2579545244","title":"聖湘生物(688289.SH)四款產品取得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2579545244","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579545244?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:50","pubTimestamp":1761904233,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣湘生物 发布公告，公司的四款产品于近日收到由国家药品监督管理局颁发的《医疗器械注册证》，包括呼吸道合胞病毒核酸检测试剂盒、甲型流感病毒、乙型流感病毒、腺病毒核酸检测试剂盒、甲型流感病毒、乙型流感病毒、肺炎支原体核酸检测试剂盒和人鼻病毒、腺病毒、肺炎支原体核酸检测试剂盒。公司本次获证的四款产品均采用多重荧光PCR技术，具备高灵敏度、高特异性、操作简便等优势，最快可在30分钟内完成精准鉴别。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09996","BK1100","BK0239","159883","BK1222","09997","BK1583","688289"],"gpt_icon":0},{"id":"2579498056","title":"藥明巨諾與再生元簽署戰略合作補充協議，攜手加速TCR-T療法開發","url":"https://stock-news.laohu8.com/highlight/detail?id=2579498056","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579498056?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:40","pubTimestamp":1761903600,"startTime":"0","endTime":"0","summary":"通过本次补充协议，药明巨诺将获得最高可达5,000万美金的付款，包括MAGE-A4产品开发里程碑付款、药品生产流程监管里程碑付款、选择权行使费、慢病毒载体制造流程里程碑付款。根据补充协议，再生元将为药明巨诺的MAGE-A4靶点产品相关特定开发活动提供资金，于签署修订协议后向本公司支付首付款，并于达成补充协议所载特定开发里程碑事件时支付一系列一次性、不可退还的里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4812260_ZH12260_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1583","BK1161","BK1574","02126"],"gpt_icon":0},{"id":"2579245144","title":"2025年西藥行業市場發展現狀趨勢分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2579245144","media":"中研网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579245144?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:39","pubTimestamp":1761903584,"startTime":"0","endTime":"0","summary":"2025年西药行业市场发展现状趋势分析在人口老龄化加速、医疗技术革新与政策红利的三重驱动下，中国西药行业正经历从“规模扩张”到“质量跃升”的关键转型。据中研产业研究院《2025-2030年中国西药行业竞争分析及发展前景预测报告》分析二、西药产业链及市场规模1. 上游：原料药国产化与CDMO崛起原料药是西药产业的基石。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031173949a47fb7a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU1046422090.SGD","06160","LU2125910500.SGD","09995","01177","BK1576","LU0708995583.HKD","LU2045819591.USD","02196","LU2242644610.SGD","BK1574","BK1583","01801","01276","09969","03692","LU0052750758.USD","02359","LU0320764599.SGD","SBHMY","01093","06978","BK1141"],"gpt_icon":0},{"id":"2580465445","title":"2025 ESMO口頭報告︱恆瑞創新藥HRS-7058治療KRAS G12C突變實體瘤I期研究結果發佈","url":"https://stock-news.laohu8.com/highlight/detail?id=2580465445","media":"恒瑞医药","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580465445?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:28","pubTimestamp":1761902907,"startTime":"0","endTime":"0","summary":"研究结果显示，HRS-7058在KRAS G12C突变晚期实体瘤中具有可控的安全性和有前景的抗肿瘤活性。KRAS G12C是KRAS突变的主要亚型之一。HRS-7058是恒瑞医药自主研发的一款新型口服KRAS G12C抑制剂，它能与KRAS G12C突变体的半胱氨酸发生不可逆结合，将该蛋白锁定在失活状态，从而阻断下游信号传导并发挥抗肿瘤作用。HRS-7058在CRC、PDAC以及KRAS G12C抑制剂经治NSCLC患者中，同样显示出治疗潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031175559a47fbfc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031175559a47fbfc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01276","BK1574","LU1023057109.AUD","BK1161","LU0359202008.SGD","LU0359201885.HKD","LU2543165471.USD","LU0359201612.USD","06978"],"gpt_icon":0},{"id":"2579346609","title":"和譽醫藥2025研發日成功舉辦，展示創新管線佈局與前沿臨牀進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2579346609","media":"医药魔方Info","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579346609?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:17","pubTimestamp":1761902269,"startTime":"0","endTime":"0","summary":"2025年10月30日，和誉医药2025研发日在上海成功举办。本次活动以“和力聚梦 誉创未来”为主题，汇聚了数十家国内外投资机构代表、临床专家和媒体人士，与和誉医药管理层及研发团队共话公司创新研发布局和临床进展。ABSK043联合其他药物用于晚期NSCLC和胃癌一线治疗的II期临床研究正在进行中。通过此次研发日活动，和誉医药全面展示了其创新研发实力与前沿临床进展，彰显公司在肿瘤及其他领域持续拓展产品管线的战略决心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180912a47fc65e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180912a47fc65e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1574","09939","BK1161","02256","BK1515"],"gpt_icon":0},{"id":"2580415605","title":"諾誠健華11月13日舉行董事會會議考慮及批准第三季度業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2580415605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580415605?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:39","pubTimestamp":1761899952,"startTime":"0","endTime":"0","summary":"格隆汇10月31日丨诺诚健华(09969.HK)宣布，公司将于2025年11月13日(星期四)举行董事会会议，藉以(其中包括)考虑及批准公司及其附属公司截至2025年9月30日止九个月之未经审核第三季度业绩及其发布。财经频道更多独家策划、专家专栏，免费查阅>>责任编辑：钟离","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031164313a47f99df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031164313a47f99df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2580141561","title":"每日沽空追蹤 | 諾誠健華 10月31日沽空量成交151.5萬股，沽空比例為10.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580141561","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580141561?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899437,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间10月31日，涨3.34%，卖空量成交151.5万股，较上一交易日减少15.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163550a47f94f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163550a47f94f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2580644867","title":"每日沽空追蹤 | 亞盛醫藥-B 10月31日沽空量成交32.41萬股，沽空比例為9.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580644867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580644867?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899432,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间10月31日，涨2.31%，卖空量成交32.41万股，较上一交易日增加29.23%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163511a6d87c00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163511a6d87c00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06855","BK1161","BK1574"],"gpt_icon":0},{"id":"2580853449","title":"每日沽空追蹤 | 華領醫藥-B 10月31日沽空量成交13.3萬股，沽空比例為3.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580853449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580853449?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899428,"startTime":"0","endTime":"0","summary":"华领医药-B北京时间10月31日，涨0.57%，卖空量成交13.3万股，较上一交易日减少34.16%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163444974bf2a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163444974bf2a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02552","BK1574"],"gpt_icon":0},{"id":"2579467085","title":"每日沽空追蹤 | 科濟藥業-B 10月31日沽空量成交13.9萬股，沽空比例為21.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579467085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579467085?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899425,"startTime":"0","endTime":"0","summary":"科济药业-B北京时间10月31日，涨1.17%，卖空量成交13.9万股，较上一交易日减少69.91%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116340794e71fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116340794e71fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1585","BK1161","BK1574","02171","BK1587"],"gpt_icon":0},{"id":"2580416754","title":"每日沽空追蹤 | 歌禮制藥-B 10月31日沽空量成交30.4萬股，沽空比例為8.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416754?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:30","pubTimestamp":1761899421,"startTime":"0","endTime":"0","summary":"歌礼制药-B北京时间10月31日，涨3.65%，卖空量成交30.4万股，较上一交易日减少25.31%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163323974bf1f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163323974bf1f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1191","BK1161","01672","01477"],"gpt_icon":0},{"id":"2580241681","title":"21個獨家中成藥火熱！華潤、國藥領跑，雲南白藥暴漲396%，28款中藥新藥瞄準百億市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2580241681","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580241681?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:24","pubTimestamp":1761899043,"startTime":"0","endTime":"0","summary":"TOP7品牌2025H1销售额均超过3000万元。11个品牌销售额涨幅达两位数及以上，其中，贵州弘泽制药的制酸止痛胶囊暴涨3387.32%、云南白药的参苓健脾胃颗粒暴涨1326.27%、沈阳绿洲制药的固本益肠片暴涨147.71%、未来药物的雪山胃宝丸大涨90.55%、上海黄海制药的扶正化瘀胶囊大涨82%。2025H1该产品销售额暴涨3387.32%至超2000万元，跻身消化系统疾病中成药品牌榜单前列，排在第十三位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163913a47f9773&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031163913a47f9773&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2088748376.SGD","BK1191","LU1008478684.HKD","IE0008368742.USD","LU0650527681.SGD","LU0594300419.USD","LU0359202008.SGD","LU1366334651.USD","SG9999009997.SGD","01477","LU2088747725.USD","LU0516423091.SGD","BK1570","LU0417516902.SGD","BK1555","LU1152091168.USD","LU1242518857.USD","LU2088748020.USD","LU0348825331.USD","LU1242518931.SGD","BK1521","LU0501845795.SGD","LU1993786604.SGD","LU1960683339.HKD","LU2088748293.HKD","LU0516422952.EUR","SG9999014674.SGD","LU0594300179.USD","LU0738912210.USD","SG9999010052.SGD","LU0880133367.SGD","LU0370786039.SGD","LU0516422366.SGD","LU0605514214.HKD","LU0251144936.SGD","BK1589","LU0072913022.USD","LU1366334578.USD","BK1574","LU0414403682.SGD","LU0979878070.USD","LU2088747998.USD","LU0067412154.USD","BK1240","LU0791591158.USD","SG9999010078.USD","01109","LU1880383366.USD","LU0173614495.USD","LU0287142896.SGD"],"gpt_icon":0},{"id":"2579960824","title":"復宏漢霖CEO朱儁：創新藥出海忌迷信經驗、「倚老賣老」｜36氪專訪","url":"https://stock-news.laohu8.com/highlight/detail?id=2579960824","media":"36氪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579960824?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:22","pubTimestamp":1761898931,"startTime":"0","endTime":"0","summary":"今年上半年，复宏汉霖的总营收为28亿元、净利润3.9亿元。在谈及推动新药出海方面的经验时，他犀利指出，做创新药忌讳“倚老卖老”，最大的经验是“不要被经验限制”。谈及在推动新药出海方面的经验时，朱俊认为，做创新药忌讳“倚老卖老”，尤其是在和全球不同的监管部门沟通时，经验有时反倒会成为“包袱”。据了解，复宏汉霖在这项研究上的投入已接近2亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031162512a6d875ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031162512a6d875ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","06978","BK1574","BK1161"],"gpt_icon":0},{"id":"2580440794","title":"心瑋醫療-B10月31日主力淨流入21.2萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2580440794","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580440794?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898559,"startTime":"0","endTime":"0","summary":"10月31日, 心玮医疗-B股价涨1.77%，报收54.50元，成交金额59.7万元，换手率0.04%，振幅2.89%，量比0.32。心玮医疗-B今日主力资金净流入21.2万元，上一交易日主力净流出47.3万元。该股近5个交易日下跌0.27%，主力资金累计净流入15.9万元；近20日主力资金累计净流出46.0万元，其中净流出天数为4日。该股主力净额占比0.01%，港股市场排名295/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116233194e71aa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116233194e71aa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06609","BK1100","BK1587","BK1574"],"gpt_icon":0},{"id":"2580416731","title":"歌禮制藥-B10月31日獲主力加倉577.7萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416731","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416731?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898557,"startTime":"0","endTime":"0","summary":"10月31日, 歌礼制药-B股价涨3.65%，报收9.65元，成交金额3623.7万元，换手率0.38%，振幅6.55%，量比1.34。歌礼制药-B今日主力资金净流入577.7万元，上一交易日主力净流入33.4万元。该股近5个交易日上涨6.33%，主力资金累计净流入479.8万元；近20日主力资金累计净流出751.2万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116232394e71a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116232394e71a93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01672","01477","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2580131484","title":"沛嘉醫療-B10月31日主力淨流入59.5萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2580131484","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580131484?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898545,"startTime":"0","endTime":"0","summary":"10月31日, 沛嘉医疗-B股价涨5.08%，报收6.00元，成交金额937.1万元，换手率0.23%，振幅6.65%，量比1.70。沛嘉医疗-B今日主力资金净流入59.5万元，上一交易日主力净流出0万元。该股近5个交易日上涨0.17%，主力资金累计净流入59.5万元；近20日主力资金累计净流出407.6万元，其中净流出天数为7日。该股主力净额占比0.01%，港股市场排名276/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031162056974bebf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031162056974bebf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","09996","BK1583","BK1574"],"gpt_icon":0},{"id":"2580428264","title":"邁博藥業-B10月31日主力淨流出25.4萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2580428264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580428264?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898537,"startTime":"0","endTime":"0","summary":"10月31日, 迈博药业-B股价跌8.77%，报收0.52元，成交金额87.9万元，换手率0.04%，振幅7.02%，量比5.15。迈博药业-B今日主力资金净流出25.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌13.33%，主力资金累计净流出25.4万元；近20日主力资金累计净流出86.9万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161933a6d871c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161933a6d871c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02181","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":30,"pageCount":2,"totalSize":584,"code":"91000000","status":"200"}]}}